Table 1: Characteristics of 19 clinical samples.

Clade Pre-treatment HIV-1 RNA (copies/ml)* HIV-1 RNA (copies/ml)** HIV-1 DNA total (copies/million cells) HIV-1 RNA < 50 copies (months) CD4+ T-cell nadir CD4+ T-cell count
B 28755 Det 6.5 99 40 200
B 926000 Neg Neg 91 20 340
B 76901 11.5 26.7 102 150 660
B 293000 5.2 3.1 39 300 780
B 20600 2.8 79.1 57 150 650
B 1000001 Det 0.8 39 1 360
B 784000 7.7 26.8 92 90 840
B 9447 Neg 16.2 52 160 860
B 74135 34.2 59.7 33 100 170
B 41264 Det 1.4 120 200 780
B 1800000 Det 15.4 8 210 400
C 84200 Neg 24 33 170 360
C 42000 2.3 11 71 54 310
C 40073 Neg 3.3 16 170 500
C 37900 Neg 17.8 16 170 500
D 62100 9.7 1.5 5 10 610
F 750000 3.4 155.6 28 130 190
CRF01_AE 750000 Det Neg 58 160 630
CRF01_AE 448000 5.9 Neg 98 30 370

Det: Detected but not quantified; Neg: Negative; *The COBAS Taqman HIV-1 test, version 2.0 (Roche); **Ultrasensitive HIV-1 RNA assay.